Eurofarma Innovation and Growth Strategy

26 Latin America Pharma Total Market (Retail + Non-Retail) Market- MAT Total US$54.3 bn Venezuela Peru Uruguay Ecuardor 3% Chile 3% 1% Central America + 4% 1% Dominican Republic 6% Colombia 9% 10% Argentina 20% Mexico Brazil 44% 1- Source: IQVIA Mar/2022 | Retail PPP / Non Retail - Reais PP, excluding Covid-19 vaccines (R$163.4 bi considering vaccines). eurofarma ■ Latin America According to IQVIA, the Latin America market (retail + non-retail) is expected to grow 11-14% per year between 2022 and 2025 Population aging and lifestyle habits drive demand for medicines According to a study from the Latin American Development Bank, nowadays 8% of the population is 65 years old or over (below the European average, at 17.5%). ■ It is estimated that the LatAm population over 65 years old will reach 30% by 2050 ■ Economic recovery post-Covid ■ Increased access in retail through greater adoption of generics and in non-retail through biosimilar adoption

View entire presentation